However, the C5a and C5 serum levels of patients with BC (n=27) exhibited a remarkable reduction, compared to healthy volunteers (n=20) (C5a: P<0.001, Figure 1C; C5: P<0.001, Figure 1D). This evidence concerns the gene C5AR1 and breast cancer.